150 related articles for article (PubMed ID: 30038012)
1. Junctional membrane Ca
Cully TR; Choi RH; Bjorksten AR; Stephenson DG; Murphy RM; Launikonis BS
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8215-8220. PubMed ID: 30038012
[TBL] [Abstract][Full Text] [Related]
2. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
[TBL] [Abstract][Full Text] [Related]
3. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia and excitation-contraction coupling.
Melzer W; Dietze B
Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
Glover L; Heffron JJ; Ohlendieck K
J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
[TBL] [Abstract][Full Text] [Related]
6. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
[TBL] [Abstract][Full Text] [Related]
7. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
[TBL] [Abstract][Full Text] [Related]
8. Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor.
Takekura H; Nishi M; Noda T; Takeshima H; Franzini-Armstrong C
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3381-5. PubMed ID: 7724570
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes.
Mickelson JR; Ervasti JM; Litterer LA; Campbell KP; Louis CF
Am J Physiol; 1994 Jul; 267(1 Pt 1):C282-92. PubMed ID: 8048487
[TBL] [Abstract][Full Text] [Related]
10. Leaky ryanodine receptors delay the activation of store overload-induced Ca2+ release, a mechanism underlying malignant hyperthermia-like events in dystrophic muscle.
Cully TR; Launikonis BS
Am J Physiol Cell Physiol; 2016 Apr; 310(8):C673-80. PubMed ID: 26825125
[TBL] [Abstract][Full Text] [Related]
11. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
Wehner M; Rueffert H; Koenig F; Olthoff D
Genet Test; 2003; 7(3):203-11. PubMed ID: 14641996
[TBL] [Abstract][Full Text] [Related]
12. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
Beard NA; Laver DR; Dulhunty AF
Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
[TBL] [Abstract][Full Text] [Related]
13. Effects of a domain peptide of the ryanodine receptor on Ca2+ release in skinned skeletal muscle fibers.
Lamb GD; Posterino GS; Yamamoto T; Ikemoto N
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C207-14. PubMed ID: 11401843
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.
Eltit JM; Ding X; Pessah IN; Allen PD; Lopez JR
FASEB J; 2013 Mar; 27(3):991-1000. PubMed ID: 23159934
[TBL] [Abstract][Full Text] [Related]
15. Arg(615)Cys substitution in pig skeletal ryanodine receptors increases activation of single channels by a segment of the skeletal DHPR II-III loop.
Gallant EM; Curtis S; Pace SM; Dulhunty AF
Biophys J; 2001 Apr; 80(4):1769-82. PubMed ID: 11259290
[TBL] [Abstract][Full Text] [Related]
16. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
17. The ryanodine receptor: a pivotal Ca2+ regulatory protein and potential therapeutic drug target.
Dulhunty AF; Casarotto MG; Beard NA
Curr Drug Targets; 2011 May; 12(5):709-23. PubMed ID: 21291389
[TBL] [Abstract][Full Text] [Related]
18. Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia.
Kitagawa Y; Sato J; Kuriyama M; Sano K; Hashimoto K
Odontology; 2011 Jan; 99(1):101-104. PubMed ID: 21271335
[TBL] [Abstract][Full Text] [Related]
19. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
20. Ca(2+) sparks operated by membrane depolarization require isoform 3 ryanodine receptor channels in skeletal muscle.
Pouvreau S; Royer L; Yi J; Brum G; Meissner G; Ríos E; Zhou J
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5235-40. PubMed ID: 17360329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
